Asklepian Consulting is a boutique consultancy exclusively focused on the strategic and commercial analysis of of cell and gene therapies, regenerative medicines,
and biogerontological therapeutics

 

Asklepian Consulting CEO Dr Nafees N. Malik publishes five industry leading frameworks for the commercialisation of CAR T-cell and other advanced therapies:

Asklepian Consulting CEO Dr Nafees N. Malik publishes first-ever manufacturing cost analysis of allogeneic vs autologous cell therapy:

Asklepian Consulting CEO Dr Nafees N. Malik interviewed by RegMedNet.com: